Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

We conduct this clinical trial to determine the effects of Xuefu Zhuyu capsule (based on TCM "Zheng Hou" theory) in helping recovery from coronary heart disease(CHD)after PCI and find out whether this kind of effecacy is much better within patients administered with TCM syndrome-based individualized medication.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Collaborator: Beijing Anzhen Hospital

Criteria

Inclusion Criteria:

• 18-75 years old

• Clinical diagnosis of coronary heart disease (confirmed by coronary angiography)

• Successfully received interventional therapy (PTCA or PCI)

• belong to TCM blood-stasis syndrome

• Must be able to swallow tablets

• Able to give written informed consent

Exclusion Criteria:

• Symptomatic congestive heart failure(New York Heart Association class III-IV)

• Females during pregnancy or lactation

• Serious dysfunction in important organs (liver, lung, kidney，et al)

• Use of concomitant Chinese herbal medicine

• Already attend other clinical trial